{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:36:49Z","timestamp":1792787809098,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Umea University","id":[{"id":"https:\/\/ror.org\/05kb8h459","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>High interdialytic weight gain (IDWG) and ultrafiltration rate have been associated with increased mortality in patients undergoing haemodialysis. Cardiac biomarkers reflecting strain, including N-terminal pro-B-type natriuretic peptide (NT-proBNP) and high-sensitivity troponin T (TnT), are known to increase during haemodialysis sessions. Previous studies suggest that these intradialytic increases may be related to ultrafiltration rate, with a proposed threshold of 0.6 IDWG per hour. This study therefore aimed to prospectively evaluate whether reducing ultrafiltration rate attenuates the haemodialysis-associated increase in these cardiac biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>In this multicentre, prospective study prevalent haemodialysis patients with a relative IDWG\u2009&gt;\u20092.5% of body weight and ultrafiltration rate\u2009\u2265\u20090.72 IDWG per hour underwent one standard and one prolonged haemodialysis session with a\u2009\u2265\u200920% reduction in ultrafiltration rate, targeting an ultrafiltration rate\u2009\u2264\u20090.6 IDWG per hour. NT-proBNP and TnT were analysed directly before dialysis, at 180\u2009minutes, and at the end of each haemodialysis session.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 238 screened patients, 65\u2009met the inclusion criteria and none of the exclusion criteria. Of these, 56 were enrolled and 41 included in the final analysis, meeting the pre-specified sample size required to detect a clinically relevant difference. NT-proBNP and TnT increased significantly during both dialysis sessions (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). However, no difference was observed in \u2206NT-proBNP (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.967) or \u2206TnT (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.823) between treatments with different ultrafiltration rates. Achieving an ultrafiltration rate\u2009\u2264\u20090.6 IDWG per hour required a mean treatment duration of 423\u2009\u00b1\u2009139\u2009minutes (min 246, max 775). Among the 12 patients (29.3%) who achieved the targeted ultrafiltration rate of \u22640.6 IDWG per hour, changes in NT-proBNP (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.062) and TnT (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.114) did not differ significantly between sessions with different ultrafiltration rates.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In stable, prevalent haemodialysis patients who tolerate their ordinary treatment, reducing the ultrafiltration rate by at least 20% did not attenuate the increase in NT-proBNP and TnT during a single haemodialysis session. In these patients, achieving an ultrafiltration rate\u2009\u2264\u20090.6 IDWG\/h generally required treatment durations that are not feasible in routine in-centre haemodialysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Registered at clinicaltrials.gov (NCT06153888) November 6 2023 (Retrospectively registered).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-026-05364-4","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:12:27Z","timestamp":1789578747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of reduced ultrafiltration rate on the cardiac biomarkers NT-proBNP and troponin T: a prospective crossover study"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8340-4517","authenticated-orcid":false,"given":"Emelie","family":"Laveborn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3928-4157","authenticated-orcid":false,"given":"Fredrik","family":"Uhlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Tzimas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5255-6674","authenticated-orcid":false,"given":"Anna","family":"W\u00e4rme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8307-0685","authenticated-orcid":false,"given":"Ainhoa","family":"Indurain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Flesche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7878-7128","authenticated-orcid":false,"given":"Ellinor","family":"Bergdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9001-614X","authenticated-orcid":false,"given":"Hans","family":"Furuland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2517-829X","authenticated-orcid":false,"given":"Anders","family":"Fernstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7545-5585","authenticated-orcid":false,"given":"Maria K.","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2694-7035","authenticated-orcid":false,"given":"Bernd","family":"Stegmayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2393-9750","authenticated-orcid":false,"given":"Michael","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"issue":"10","key":"5364_CR1","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/ndt\/gfae040","volume":"39","author":"VS Stel","year":"2024","unstructured":"Stel VS, Boenink R, Astley ME, Boerstra BA, Radunovic D, Skrunes R, et al. A comparison of the epidemiology of kidney replacement therapy between Europe and the United States: 2021 data of the ERA registry and the USRDS. Nephrol Dial Transpl. 2024;39(10):1593\u2013603. https:\/\/doi.org\/10.1093\/ndt\/gfae040.","journal-title":"Nephrol Dial Transpl"},{"key":"5364_CR2","doi-asserted-by":"publisher","unstructured":"Boerstra BA, Boenink R, Astley ME, Bonthuis M, Abd ElHafeez S, Arribas Monzon F, et al. The ERA registry annual report 2021: a summary. Clin Kidney J. 2024;17(2):sfad281. https:\/\/doi.org\/10.1093\/ckj\/sfad281.","DOI":"10.1093\/ckj\/sfad281"},{"issue":"1","key":"5364_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s42399-022-01347-2","volume":"5","author":"A Minciunescu","year":"2022","unstructured":"Minciunescu A, Genovese L, DeFilippi C. Cardiovascular alterations and structural changes in the setting of chronic kidney disease: a review of cardiorenal syndrome type 4. SN Compr Clin Med. 2022;5(1):15. https:\/\/doi.org\/10.1007\/s42399-022-01347-2.","journal-title":"SN Compr Clin Med"},{"issue":"19","key":"5364_CR4","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","volume":"52","author":"C Ronco","year":"2008","unstructured":"Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52(19):1527\u201339. https:\/\/doi.org\/10.1016\/j.jacc.2008.07.051.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"5364_CR5","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.2215\/CJN.04470709","volume":"4","author":"JO Burton","year":"2009","unstructured":"Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol. 2009;4(12):1925\u201331. https:\/\/doi.org\/10.2215\/CJN.04470709.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"5364_CR6","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1525-139X.2008.00454.x","volume":"21","author":"ML Gross","year":"2008","unstructured":"Gross ML, Ritz E. Non-coronary heart disease in dialysis patients: hypertrophy and fibrosis in the cardiomyopathy of Uremia\u2014beyond coronary heart disease. Semin Dial. 2008;21(4):308\u201318. https:\/\/doi.org\/10.1111\/j.1525-139X.2008.00454.x.","journal-title":"Semin Dial"},{"key":"5364_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/8816478","volume":"2023","author":"NN Nguyen","year":"2023","unstructured":"Nguyen NN, Van Duong P, Ngoc Mai TH, Vo NH, Luong DK, Ngo TH. Left ventricular Mass index in end-Stage renal disease patients during hemodialysis and continuous ambulatory peritoneal dialysis. Int J Clin practiceInt J Clin Pract. 2023;2023:1\u20137. https:\/\/doi.org\/10.1155\/2023\/8816478.","journal-title":"Int J Clin practiceInt J Clin Pract"},{"issue":"1","key":"5364_CR8","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41598-023-50746-5","volume":"14","author":"BG Han","year":"2024","unstructured":"Han BG, Pak D, Kim JS, Sohn Y. The moderating effect of fluid overload on the relationship between the augmentation index and left ventricular diastolic function in patients with CKD. Sci Rep. 2024;14(1):480. https:\/\/doi.org\/10.1038\/s41598-023-50746-5.","journal-title":"Sci Rep"},{"issue":"6","key":"5364_CR9","doi-asserted-by":"publisher","first-page":"870","DOI":"10.34067\/KID.0000000000000443","volume":"5","author":"E Elsayed","year":"2024","unstructured":"Elsayed E, Farag YMK, Ravi KS, Chertow GM, Mc Causland FR. Association of changes in vector length with changes in left ventricular Mass among patients on maintenance hemodialysis: a secondary analysis of the frequent hemodialysis network daily trial. Kidney360. 2024;5(6):870\u201376. https:\/\/doi.org\/10.34067\/KID.0000000000000443.","journal-title":"Kidney360"},{"key":"5364_CR10","doi-asserted-by":"publisher","unstructured":"Christa M, Smyth B, Mayne KJ, Stuard S, Canaud B, Genser B, et al. Increased risk of cardiac death with cumulative exposure to fluid overload and dialysate sodium \u2264138 mmol\/l in hemodialysis patients. Clin Kidney J. 2025;18(10):sfaf259. https:\/\/doi.org\/10.1093\/ckj\/sfaf259.","DOI":"10.1093\/ckj\/sfaf259"},{"issue":"1","key":"5364_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1542-4758.2009.00335.x","volume":"13","author":"B Holmberg","year":"2009","unstructured":"Holmberg B, Stegmayr BG. Cardiovascular conditions in hemodialysis patients may be worsened by extensive interdialytic weight gain. Hemodial Int. 2009;13(1):27\u201331. https:\/\/doi.org\/10.1111\/j.1542-4758.2009.00335.x.","journal-title":"Hemodial Int"},{"issue":"11","key":"5364_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.5414\/CN106858","volume":"76","author":"BD Westenbrink","year":"2011","unstructured":"Westenbrink BD, Hovinga TK, Kloppenburg WD, Veeger NJ, Janssen WM. B-type natriuretic peptide and interdialytic fluid retention are independent and incremental predictors of mortality in hemodialysis patients. CN. 2011;76(11):373\u201379. https:\/\/doi.org\/10.5414\/CN106858.","journal-title":"CN"},{"issue":"7","key":"5364_CR13","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/sj.ki.5000186","volume":"69","author":"R Saran","year":"2006","unstructured":"Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int. 2006;69(7):1222\u201328. https:\/\/doi.org\/10.1038\/sj.ki.5000186.","journal-title":"Kidney Int"},{"issue":"12","key":"5364_CR14","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1093\/ndt\/gfm466","volume":"22","author":"E Movilli","year":"2007","unstructured":"Movilli E, Gaggia P, Zubani R, Camerini C, Vizzardi V, Parrinello G, et al. Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. Nephrol Dial Transpl. 2007;22(12):3547\u201352. https:\/\/doi.org\/10.1093\/ndt\/gfm466.","journal-title":"Nephrol Dial Transpl"},{"issue":"2","key":"5364_CR15","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/ki.2010.383","volume":"79","author":"JE Flythe","year":"2011","unstructured":"Flythe JE, Kimmel SE, Brunelli SM. Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int. 2011;79(2):250\u201357. https:\/\/doi.org\/10.1038\/ki.2010.383.","journal-title":"Kidney Int"},{"issue":"6","key":"5364_CR16","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1053\/j.ajkd.2016.06.020","volume":"68","author":"MM Assimon","year":"2016","unstructured":"Assimon MM, Wenger JB, Wang L, Flythe JE. Ultrafiltration rate and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2016;68(6):911\u201322. https:\/\/doi.org\/10.1053\/j.ajkd.2016.06.020.","journal-title":"Am J Kidney Dis"},{"key":"5364_CR17","doi-asserted-by":"publisher","unstructured":"Navarrete JE, Rajabalan A, Cobb J, Lea JP. Proportion of hemodialysis treatments with high ultrafiltration rate and the association with mortality. Kidney360. 2022;3, 3(8):1359\u201366. https:\/\/doi.org\/10.34067\/KID.0001322022.","DOI":"10.34067\/KID.0001322022"},{"issue":"6","key":"5364_CR18","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.2215\/CJN.05200610","volume":"6","author":"HJ Jefferies","year":"2011","unstructured":"Jefferies HJ, Virk B, Schiller B, Moran J, McIntyre CW. Frequent hemodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (myocardial stunning). Clin J Am Soc Nephrol. 2011;6(6):1326\u201332. https:\/\/doi.org\/10.2215\/CJN.05200610.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"5364_CR19","doi-asserted-by":"publisher","first-page":"914","DOI":"10.2215\/CJN.03900808","volume":"4","author":"JO Burton","year":"2009","unstructured":"Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol. 2009;4(5):914\u201320. https:\/\/doi.org\/10.2215\/CJN.03900808.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"5364_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3934\/genet.2017.1.1","volume":"4","author":"U Mahmood","year":"2017","unstructured":"Mahmood U, Johnson DW, Fahim MA. Cardiac biomarkers in dialysis. Aims Genet. 2017;4(1):1\u201320. https:\/\/doi.org\/10.3934\/genet.2017.1.1.","journal-title":"Aims Genet"},{"issue":"1","key":"5364_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/1744-9987.12593","volume":"22","author":"K Yamashita","year":"2018","unstructured":"Yamashita K, Mizuiri S, Nishizawa Y, Shigemoto K, Doi S, Masaki T. Addition of novel biomarkers for predicting all-cause and cardiovascular mortality in prevalent hemodialysis patients. Ther Apher Dial. 2018;22(1):31\u201339. https:\/\/doi.org\/10.1111\/1744-9987.12593.","journal-title":"Ther Apher Dial"},{"issue":"1","key":"5364_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/0886022X.2018.1437047","volume":"40","author":"C Kawagoe","year":"2018","unstructured":"Kawagoe C, Sato Y, Toida T, Nakagawa H, Yamashita Y, Fukuda A, et al. N-terminal-pro-B-type-natriuretic peptide associated with 2-year mortality from both cardiovascular and non-cardiovascular origins in prevalent chronic hemodialysis patients. Ren Fail. 2018;40(1):127\u201334. https:\/\/doi.org\/10.1080\/0886022X.2018.1437047.","journal-title":"Ren Fail"},{"issue":"2","key":"5364_CR23","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/ehf2.13784","volume":"9","author":"M Eriguchi","year":"2022","unstructured":"Eriguchi M, Tsuruya K, Lopes M, Bieber B, McCullough K, Pecoits-Filho R, et al. Routinely measured cardiac troponin I and N-terminal pro-B-type natriuretic peptide as predictors of mortality in haemodialysis patients. ESC Heart Fail. 2022;9(2):1138\u201351. https:\/\/doi.org\/10.1002\/ehf2.13784.","journal-title":"ESC Heart Fail"},{"issue":"25","key":"5364_CR24","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1016\/j.jacc.2007.09.021","volume":"50","author":"LB Daniels","year":"2007","unstructured":"Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007;50(25):2357\u201368. https:\/\/doi.org\/10.1016\/j.jacc.2007.09.021.","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"5364_CR25","doi-asserted-by":"publisher","first-page":"10928","DOI":"10.3390\/ijms222010928","volume":"22","author":"AM Chaulin","year":"2021","unstructured":"Chaulin AM. Cardiac troponins metabolism: from biochemical mechanisms to clinical practice (literature review). IJMS. 2021;22(20):10928. https:\/\/doi.org\/10.3390\/ijms222010928.","journal-title":"IJMS"},{"issue":"2","key":"5364_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5301\/ijao.5000387","volume":"38","author":"E Laveborn","year":"2015","unstructured":"Laveborn E, Lindmark K, Skagerlind M, Stegmayr B. NT-proBNP and troponin T levels differ after haemodialysis with a low versus high flux membrane. Int J Artif Organs. 2015;38(2):69\u201375. https:\/\/doi.org\/10.5301\/ijao.5000387.","journal-title":"Int J Artif Organs"},{"issue":"8","key":"5364_CR27","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1177\/0391398820981385","volume":"44","author":"J Goto","year":"2021","unstructured":"Goto J, Forsberg U, Jonsson P, Matsuda K, Nilsson B, Nilsson Ekdahl K, et al. Interdialytic weight gain of less than 2.5% seems to limit cardiac damage during hemodialysis. Int J Artif Organs. 2021;44(8):539\u201350. https:\/\/doi.org\/10.1177\/0391398820981385.","journal-title":"Int J Artif Organs"},{"key":"5364_CR28","doi-asserted-by":"publisher","unstructured":"Pimenta J, Sampaio F, Martins P, Carvalho B, Rocha-Gon\u00e7alves F, Ferreira A, et al. Aminoterminal B-type natriuretic peptide (NT-proBNP) in end-stage renal failure patients on regular hemodialysis: does it have diagnostic and prognostic implications? Nephron Clin Pract. 2009;111(3):c182\u20138. https:\/\/doi.org\/10.1159\/000199458.","DOI":"10.1159\/000199458"},{"issue":"26","key":"5364_CR29","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1056\/NEJMoa1803377","volume":"380","author":"JT Neumann","year":"2019","unstructured":"Neumann JT, Twerenbold R, Ojeda F, Sorensen NA, Chapman AR, Shah ASV, et al. Application of high-sensitivity troponin in suspected myocardial infarction. N Engl J Med. 2019;380(26):2529\u201340. https:\/\/doi.org\/10.1056\/NEJMoa1803377.","journal-title":"N Engl J Med"},{"issue":"1","key":"5364_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/hdi.13124","volume":"28","author":"J Goto","year":"2024","unstructured":"Goto J, Ott M, Stegmayr B. Myocardial markers are highly altered by higher rates of fluid removal during hemodialysis. Hemodial Int. 2024;28(1):17\u201323. https:\/\/doi.org\/10.1111\/hdi.13124.","journal-title":"Hemodial Int"},{"issue":"2","key":"5364_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/MAT.0b013e318243660f","volume":"58","author":"D Schneditz","year":"2012","unstructured":"Schneditz D, Putz-Bankuti C, Ribitsch W, Schilcher G. Correction of plasma concentrations for effects of hemoconcentration or hemodilution. Asaio J. 2012;58(2):160\u201362. https:\/\/doi.org\/10.1097\/MAT.0b013e318243660f.","journal-title":"Asaio J"},{"issue":"1","key":"5364_CR32","doi-asserted-by":"publisher","first-page":"14089","DOI":"10.1038\/s41598-023-41020-9","volume":"13","author":"KM Sveric","year":"2023","unstructured":"Sveric KM, Cans\u0131z B, Winkler A, Ulbrich S, Ende G, Heidrich F, et al. Accuracy of Devereux and Teichholz formulas for left ventricular mass calculation in different geometric patterns: comparison with cardiac magnetic resonance imaging. Sci Rep. 2023;13(1):14089. https:\/\/doi.org\/10.1038\/s41598-023-41020-9.","journal-title":"Sci Rep"},{"issue":"3","key":"5364_CR33","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1525-139X.2007.00281.x","volume":"20","author":"NM Selby","year":"2007","unstructured":"Selby NM, McIntyre CW. The acute cardiac effects of dialysis. Semin Dial. 2007;20(3):220\u201328. https:\/\/doi.org\/10.1111\/j.1525-139X.2007.00281.x.","journal-title":"Semin Dial"},{"issue":"5","key":"5364_CR34","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0272-6386(00)70250-2","volume":"35","author":"WJW Bos","year":"2000","unstructured":"Bos WJW, Bruin S, van Olden RW, Keur I, Wesseling KH, Westerhof N, et al. Cardiac and hemodynamic effects of hemodialysis and ultrafiltration. Am J Kidney Dis. 2000;35(5):819\u201326. https:\/\/doi.org\/10.1016\/S0272-6386(00)70250-2.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"5364_CR35","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.nefroe.2021.10.005","volume":"41","author":"R Fernandez-Prado","year":"2021","unstructured":"Fernandez-Prado R, Pena-Esparragoza JK, Santos-Sanchez-Rey B, Pereira M, Avello A, Goma-Garces E, et al. Ultrafiltration rate adjusted to body weight and mortality in hemodialysis patients. Nefrolog\u00ed(Engl Ed). 2021;41(4):426\u201335. https:\/\/doi.org\/10.1016\/j.nefroe.2021.10.005.","journal-title":"Nefrolog\u00ed(Engl Ed)"},{"issue":"7","key":"5364_CR36","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.ekir.2022.04.079","volume":"7","author":"JG Raimann","year":"2022","unstructured":"Raimann JG, Wang Y, Mermelstein A, Kotanko P, Daugirdas JT. Ultrafiltration rate thresholds associated with increased mortality risk in Hemodialysis, unscaled or scaled to body size. Kidney Int Rep. 2022;7(7):1585\u201393. https:\/\/doi.org\/10.1016\/j.ekir.2022.04.079.","journal-title":"Kidney Int Rep"},{"issue":"12","key":"5364_CR37","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.3390\/jpm12122059","volume":"12","author":"LJ Yang","year":"2022","unstructured":"Yang LJ, Chao YL, Kuo IC, Niu SW, Hung CC, Chiu YW, et al. High ultrafiltration rate is associated with increased all-cause mortality in incident hemodialysis patients with a high Cardiothoracic ratio. J Pers Med. 2022;12(12):2059. https:\/\/doi.org\/10.3390\/jpm12122059.","journal-title":"JPM"},{"issue":"6","key":"5364_CR38","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/ckj\/sfaa078","volume":"13","author":"M Kanbay","year":"2020","unstructured":"Kanbay M, Ertuglu LA, Afsar B, Ozdogan E, Siriopol D, Covic A, et al. An update review of intradialytic hypotension: concept, risk factors, clinical implications and management. Clin Kidney J. 2020;13(6):981\u201393. https:\/\/doi.org\/10.1093\/ckj\/sfaa078.","journal-title":"Clin Kidney J"},{"issue":"4","key":"5364_CR39","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/039139880402700403","volume":"27","author":"B Charra","year":"2004","unstructured":"Charra B, Terrat JC, Vanel T, Chazot C, Jean G, Hurot JM, et al. Long thrice weekly hemodialysis: the Tassin experience. Int J Artif Organs. 2004;27(4):265\u201383. https:\/\/doi.org\/10.1177\/039139880402700403.","journal-title":"Int J Artif Organs"},{"issue":"24","key":"5364_CR40","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1056\/NEJMoa1001593","volume":"363","author":"FHNT Group","year":"2010","unstructured":"Group FHNT, Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, et al. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010;363(24):2287\u2013300.","journal-title":"N Engl J Med"},{"issue":"10","key":"5364_CR41","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/ki.2011.213","volume":"80","author":"MV Rocco","year":"2011","unstructured":"Rocco MV, Lockridge RS Jr, Beck GJ, Eggers PW, Gassman JJ, Greene T, et al. The effects of frequent nocturnal home hemodialysis: the frequent hemodialysis network nocturnal trial. Kidney Int. 2011;80(10):1080\u201391. https:\/\/doi.org\/10.1038\/ki.2011.213.","journal-title":"Kidney Int"},{"issue":"1","key":"5364_CR42","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1186\/s12882-025-04401-y","volume":"26","author":"E Avila","year":"2025","unstructured":"Avila E, Sepulveda RA, Retamal J, Hachim D. Biocompatibility in hemodialysis: artificial membrane and human blood interactions. BMC Nephrol. 2025;26(1):482. https:\/\/doi.org\/10.1186\/s12882-025-04401-y.","journal-title":"BMC Nephrol"},{"key":"5364_CR43","doi-asserted-by":"publisher","unstructured":"Forsberg U, Jonsson P, Stegmayr B. The Emboless\u00ae venous chamber efficiently reduces air bubbles: a randomized study of chronic hemodialysis patients. Clin Kidney J. 2024;17(11):sfae323. https:\/\/doi.org\/10.1093\/ckj\/sfae323.","DOI":"10.1093\/ckj\/sfae323"},{"issue":"6","key":"5364_CR44","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.3390\/jcm14061846","volume":"14","author":"M Bossola","year":"2025","unstructured":"Bossola M, Mariani I, Strizzi CT, Piccinni CP, Di Stasio E. How to limit interdialytic weight gain in patients on maintenance hemodialysis: state of the art and perspectives. J Clin Med. 2025;14(6):1846. https:\/\/doi.org\/10.3390\/jcm14061846.","journal-title":"JCM"},{"key":"5364_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clinbiochem.2020.05.013","volume":"83","author":"WL Yang","year":"2020","unstructured":"Yang WL, Fahim M, Johnson DW. Pathophysiology and significance of natriuretic peptides in patients with end-stage kidney disease. Clin Biochem. 2020;83:1\u201311. https:\/\/doi.org\/10.1016\/j.clinbiochem.2020.05.013.","journal-title":"Clin Biochem"},{"issue":"11","key":"5364_CR46","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1161\/CIRCULATIONAHA.120.046574","volume":"143","author":"\u00c1 Arnadottir","year":"2021","unstructured":"Arnadottir \u00c1, Pedersen S, Bo Hasselbalch R, Goetze JP, Friis-Hansen LJ, Bloch-Munster AM, et al. Temporal release of high-sensitivity cardiac troponin T and I and copeptin after brief induced coronary artery balloon occlusion in humans. Circulation. 2021;143(11):1095\u2013104. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.046574.","journal-title":"Circulation"},{"issue":"4","key":"5364_CR47","doi-asserted-by":"publisher","first-page":"376","DOI":"10.5603\/CJ.a2018.0118","volume":"27","author":"S Unlu","year":"2020","unstructured":"Unlu S, Sahinarslan A, Sezenoz B, Uludag OM, Gokalp G, Seckin \u00d6, et al. High-sensitive troponin T increase after hemodialysis is associated with left ventricular global longitudinal strain and ultrafiltration rate. Cardiol J. 2020;27(4):376\u201383. https:\/\/doi.org\/10.5603\/CJ.a2018.0118.","journal-title":"Cardiol J"},{"key":"5364_CR48","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.cca.2013.11.017","volume":"429","author":"C Liebetrau","year":"2014","unstructured":"Liebetrau C, Gaede L, Dorr O, Troidl C, Voss S, Hoffmann J, et al. Release kinetics of N-terminal pro-B-type natriuretic peptide in a clinical model of acute myocardial infarction. Clinica (Rome) Acta. 2014;429:34\u201337. https:\/\/doi.org\/10.1016\/j.cca.2013.11.017.","journal-title":"Clinica (Rome) Acta"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05364-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05364-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05364-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:21:28Z","timestamp":1789654888000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05364-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5364"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05364-4","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"20 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained from the Swedish Ethical Review Authority (2012-42-31\u2009M, revised Dnr 2023-06921-02) and complied with the Declaration of Helsinki. All participants provided written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Participants have consented to publication of aggregated data.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"547"}}